Results 101 to 110 of about 9,994 (168)

The role of genetic polymorphisms on drug response in Alzheimer's disease: a systematic review. [PDF]

BMC Med Genomics
Climacosa FMM, Ornos EDB, Gapaz NCLL, Guantia MGR, Cruz JMC, Manalo RVM, Yu ML, Qureshi AP, Carampel AC, Asis JLB, Reyes JCB, Dacasin AB, Anlacan VMM.   +12 more
europepmc   +1 more source

Evaluating the peripheral nervous system pathology of Alzheimer's disease utilizing a functional human NMJ microphysiological system. [PDF]

Alzheimers Dement
Kargazhanov A, Aiken R, Hawkins K, Lopez R, Nawaz A, Srivastava G, Miller C, Bogen W, Long C, Morgan D, Guo X, Hickman J.   +11 more
europepmc   +1 more source

Natural Chiral Scaffolds in Alzheimer's Disease: Therapeutic Potential, Mechanism, and Clinical Aspects. [PDF]

Biomed Res Int
Singh A, Sahu SK, Sah AK.
europepmc   +1 more source

Early-stage drug discovery in a new-generation ultrahigh-throughput mass spectrometry platform. [PDF]

Proc Natl Acad Sci U S A
Morato NM, Feng Y, Chen K, Huang KH, Owen A, Caruso JV, Yang B, Kulathunga SC, Mesecar AD, Klumpp-Thomas C, Radujevic A, Godfrey AG, Gardner S, Rudnicki DD, Galbraith M, Gloeckner A, Hajdu C, Pringle SD, Morris M, Balog J, Cooks RG.   +20 more
europepmc   +1 more source

SAHRANG: Subarachnoid Hemorrhage Recovery and Galantamine: A Pilot Multicenter Randomized Placebo-Controlled Trial. [PDF]

Neurocrit Care
Yang BSK, Savarraj JPJ, Moreno E, Immanuel KE, Hergenroeder G, Torres G, Kim JH, Samuel S, Pedroza C, Grotta JC, Barreto A, Choi HA.   +11 more
europepmc   +1 more source

Trends in First-Time Symptomatic Antidementia Drug Dispensations to Home-Dwelling People in Norway: A Nationwide Register-Based Study. [PDF]

Drugs Real World Outcomes
Øvrebø TG, Sunde AL, Rongve A, Kjosavik SR, Dalen I, Oesterhus R.   +5 more
europepmc   +1 more source

A physics-informed graph neural network to approximate docking-based binding affinity for DYRK2 in Alzheimer's drug repurposing. [PDF]

Sci Rep
Gider V, Budak C.
europepmc   +1 more source